Objective
The main objective of the project is to generate antibodies that specifically bind to human tumour vasculature. This will be achieved by ex vivo perfusion of surgically resected livers containing tumours, with phage display libraries. The phage display technology has already been applied successfully in in-vivo selection for tumour vasculature in mice. However, a disadvantage of this system is that while the tumour cells can be human, the vasculature is of mouse origin, and the human tumour vasculature antigens will differ.
Selection of phage displayed antibodies by perfusion of tumour-bearing organs is novel because it will give direct access to living human tumour vasculature. Using resected human liver segments, we have established a perfusion system, and demonstrated that phage are delivered to the tumour vasculature as demonstrated by immunohistochemistry.
To ensure the highest possible success rate in the perfusion-selections, we have characterised different phage display systems for display efficiency and optimised phage production protocols The selected antibodies will initially be investigated in established immunohistochemical assays, and subsequently tested for potential tumour vascular targeting using resected tumour-bearing organs in our perfusion system. The perfusion-selection of phage-display libraries described offers a unique opportunity to generate clinically relevant antibodies or peptides for anti-vascular cancer therapy and to identify important human tumour vascular antigens.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences microbiology virology
- natural sciences biological sciences biochemistry biomolecules
- medical and health sciences clinical medicine oncology
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2004-MOBILITY-5
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
LONDON
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.